SWOT Analysis for Arcadia Biosciences Inc

Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Companies with Low Debt
Annual Net Profits improving for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Oversold by Money Flow Index (MFI)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Profit to Loss Companies
Stocks Underperforming their Industry Price Change in the Quarter

Red Flags: Weakening Technicals and Share Price Decline
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter

Arcadia Biosciences Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats